Sellas Life Sciences Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 7
Employees
  • Stock Symbol
  • SLS
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $10.02
  • (As of Friday Closing)

Sellas Life Sciences General Information

Description

SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • Times Square Tower, 7 Times Square
  • Suite 2503
  • New York, NY 10036
  • United States
+1 (646) 000-0000

Sellas Life Sciences Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sellas Life Sciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.02 $10.28 $2.33 - $19.38 $159M 15.9M 444K -$1.28

Sellas Life Sciences Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 144,417 75,277 12,136 17,201
Revenue 9,500 1,900 0 0
EBITDA (15,227) (16,518) (19,491) (28,782)
Net Income (15,205) (16,757) (19,292) (27,670)
Total Assets 43,624 46,049 16,609 16,915
Total Debt 903 991 217 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sellas Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sellas Life Sciences‘s full profile, request access.

Request a free trial

Sellas Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer
Drug Discovery
New York, NY
7 As of 2020
000.00
000000000 000.00

00000000

a pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt molli
0000000000000
San Diego, CA
000 As of 0000
0.000 0000-00-00
000000&0

000000 0

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepte
0000000000000
Plymouth Meeting, PA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sellas Life Sciences Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioLegend Corporate Backed or Acquired San Diego, CA 000 000000&0
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
00000 0000000 0000 Formerly VC-backed Cambridge, MA 00 00000 0000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000000 000 Corporation New York, NY 00 00000 00000000 00000
You’re viewing 5 of 27 competitors. Get the full list »

Sellas Life Sciences Executive Team (11)

Name Title Board Seat Contact Info
Angelos Stergiou MD Chief Executive Officer and President
John Burns Chief Accounting Officer, Accounting & Controller, Finance
Barbara Wood JD Executive Vice President & General Counsel, Legal
Dragan Cicic Senior Vice President
You’re viewing 4 of 11 executive team members. Get the full list »

Sellas Life Sciences Board Members (4)

Name Representing Role Since
00000 0000000000 00.0 Sellas Life Sciences Board Member 000 0000
0000 000000 00 Self Chairman & Board Member 000 0000
0000 000000 Self Board Member 000 0000
000000 000 00000000 Self Board Member 000 0000
To view Sellas Life Sciences’s complete board members history, request access »

Sellas Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sellas Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sellas Life Sciences‘s full profile, request access.

Request a free trial

Sellas Life Sciences Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000000 29-Dec-2017 000000000000000000 0000 Biotechnology 0000000 00000000 00
To view Sellas Life Sciences’s complete acquisitions history, request access »